Macrocytosis secondary to hydroxyurea therapy. - Wikidata - awgldk - TriplyDB

Macrocytosis secondary to hydroxyurea therapy.

Macrocytosis secondary to hydroxyurea therapy.

http://www.wikidata.org/entity/Q46356093

about

Macrocytosis secondary to hydroxyurea therapy.

http://www.wikidata.org/entity/Q46356093

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Macrocytosis secondary to hydroxyurea therapy.

@en

Macrocytosis secondary to hydroxyurea therapy.

@nl

type

label

Macrocytosis secondary to hydroxyurea therapy.

@en

Macrocytosis secondary to hydroxyurea therapy.

@nl

prefLabel

Macrocytosis secondary to hydroxyurea therapy.

@en

Macrocytosis secondary to hydroxyurea therapy.

@nl

P1433

Q46356093-398E6636-1BE6-4E20-B9FF-806DE1451C18

P1476

Q46356093-FE1F0DCB-11CA-45DB-89A4-C2F0D320B56B

P2093

Q46356093-0E2ACA98-E7CC-49AE-9D07-98FCA770AAEB

Q46356093-8FB9DCD0-5016-4DC4-97A1-193777BE29A8

Q46356093-D33A5ABD-E1A7-4A9F-8690-859EB5B692AB

P2860

Q46356093-12248D26-4E91-474E-B9B0-A72ACCB1A228

Q46356093-18EADBB5-2450-44EF-8A77-0158084551F9

Q46356093-2B4E0BDC-FBD7-4839-B21A-D19CAE73BC57

Q46356093-63EBA24B-9A38-468F-BE9F-E3C423147E12

Q46356093-72EA6505-0023-4FD2-BE32-341ABA54790E

Q46356093-8C5997B1-6E1B-47F1-8B83-D4F1EC36ED41

Q46356093-AD0018D0-8177-4E92-AACD-17B7E3158BD8

Q46356093-DBCAC9CC-048F-483B-925A-5244B514DB10

P304

Q46356093-2863B7DD-8BC3-439A-B300-5CC34739FF16

P31

Q46356093-83950CEF-1D07-428D-81BA-CD279DFD1E8E

P356

Q46356093-B55F9BD4-253C-43E5-88BC-1D6FE1A27C56

P433

Q46356093-21833005-5A7C-4393-A98F-1DA5368A5274

P478

Q46356093-63573A6F-52E6-4524-806B-E1A6BA2A59C7

P50

Q46356093-A3907FBF-3A45-4DB3-A6D8-808D789E6D51

P577

Q46356093-42A9B6F1-E048-4601-90A0-016CE08E3249

P698

Q46356093-DEDACD38-01DA-4FE0-A95B-5535EE39AD24

P356

P1433

Veterinary Clinical Pathology

P1476

Macrocytosis secondary to hydroxyurea therapy

@en

P2093

Abbie L Speas

http://www.w3.org/2001/XMLSchema#string

Amy L Weeden

http://www.w3.org/2001/XMLSchema#string

Mary K Leissinger

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease

Hydroxyurea for treatment of polycythemia secondary to right-to-left shunting patent ductus arteriosus in 4 dogs.

Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs.

Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose.

Successful treatment of hypereosinophilic syndrome in a dog.

Polycythemia vera in a dog presenting with uveitis.

Comparison of manual polychromatophilic cell and automated reticulocyte quantification in evaluating regenerative response in anemic dogs.

Methaemoglobinaemia caused by hydroxycarbamide (hydroxyurea) ingestion in a dog.

P304

451-456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/VCP.12511

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

Francisco de Oliveira Conrado

P577

2017-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28582589

http://www.w3.org/2001/XMLSchema#string